Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jun 17;19(6):8220-37.
doi: 10.3390/molecules19068220.

miRNAs as non-invasive biomarkers for lung cancer diagnosis

Affiliations
Review

miRNAs as non-invasive biomarkers for lung cancer diagnosis

Paola Ulivi et al. Molecules. .

Abstract

Lung cancer is a leading cause of cancer death and late diagnosis is one of the most important reasons for the high mortality rate. Circulating microRNAs (miRNAs) represent stable and reproducible markers for numerous solid tumors, including lung cancer, and have been hypothesized as non-invasive diagnostic markers. Serum, plasma or whole peripheral blood can be used as starting material, and several methodological approaches have been proposed to evaluate miRNA expression. The present review provides an in depth summary of current knowledge on circulating miRNAs in different types of biological samples used as diagnostic markers of lung cancer. We also evaluate the diagnostic accuracy of each miRNA or group of miRNAs in relation to the different housekeeping miRNAs used. Finally, the limitations and potential of miRNA analysis are discussed.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

Cited by

References

    1. National Lung Screening Trial Research Team. Aberle D.R., Berg C.D., Black W.C., Church T.R., Fagerstrom R.M., Galen B., Gareen I.F., Gatsonis C., Goldin J., et al. The National Lung Screening Trial: Overview and Study Design. Radiology. 2011;258:243–253. doi: 10.1148/radiol.10091808. - DOI - PMC - PubMed
    1. Jemal A., Siegel R., Xu J., Ward E. Cancer Statistics, 2010. CA Cancer. J. Clin. 2010;60:277–300. doi: 10.3322/caac.20073. - DOI - PubMed
    1. Ulivi P., Silvestrini R. Role of Quantitative and Qualitative Characteristics of Free Circulating DNA in the Management of Patients with Non-Small Cell Lung Cancer. Cell. Oncol. (Dordr) 2013;36:439–448. doi: 10.1007/s13402-013-0155-3. - DOI - PubMed
    1. Sozzi G., Boeri M., Rossi M., Verri C., Suatoni P., Bravi F., Roz L., Conte D., Grassi M., Sverzellati N., et al. Clinical Utility of a Plasma-Based miRNA Signature Classifier within Computed Tomography Lung Cancer Screening: A Correlative MILD Trial Study. J. Clin. Oncol. 2014 doi: 10.1200/JCO.2013.50.4357. - DOI - PMC - PubMed
    1. Markopoulou S., Nikolaidis G., Liloglou T. DNA Methylation Biomarkers in Biological Fluids for Early Detection of Respiratory Tract Cancer. Clin. Chem. Lab. Med. 2012;50:1723–1731. - PubMed